Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humans
Year: 2009
Type: article
Abstract: Interindividual variability in response to chemicals and drugs is a common regulatory concern. It is assumed that xenobiotic-induced adverse reactions have a strong genetic basis, but many mechanism-based investigations have not been successful in identifying susceptible individuals. While recent advances in pharmacogenetics of adverse drug reactions show promise, the small size of the populations susceptible to important adverse events limits the utility of whole-genome association studies conducted entirely in humans. We present a strategy to identify genetic polymorphisms that may underlie susceptibility to adverse drug reactions. First, in a cohort of healthy adults who received the maximum recommended dose of acetaminophen (4 g/d x 7 d), we confirm that about one third of subjects develop elevations in serum alanine aminotransferase, indicative of liver injury. To identify the genetic basis for this susceptibility, a panel of 36 inbred mouse strains was used to model genetic diversity. Mice were treated with 300 mg/kg or a range of additional acetaminophen doses, and the extent of liver injury was quantified. We then employed whole-genome association analysis and targeted sequencing to determine that polymorphisms in Ly86, Cd44, Cd59a, and Capn8 correlate strongly with liver injury and demonstrated that dose-curves vary with background. Finally, we demonstrated that variation in the orthologous human gene, CD44, is associated with susceptibility to acetaminophen in two independent cohorts. Our results indicate a role for CD44 in modulation of susceptibility to acetaminophen hepatotoxicity. These studies demonstrate that a diverse mouse population can be used to understand and predict adverse toxicity in heterogeneous human populations through guided resequencing.
Source: Genome Research
Authors: Alison H. Harrill, Paul B. Watkins, Stephen Su, Pamela K. Ross, David E. Harbourt, Ioannis M. Stylianou, Gary A. Boorman, Mark W. Russo, Richard S. Sackler, Stephen C. Harris, Philip C. Smith, Raymond Tennant, Molly Bogue, Kenneth Paigen, Christopher Harris, Tanupriya Contractor, Timothy Wiltshire, Ivan Rusyn, David W. Threadgill
Institutions: University of North Carolina at Chapel Hill, The Hamner Institutes for Health Sciences, Genomics Institute of the Novartis Research Foundation, Jackson Laboratory, National Institute of Environmental Health Sciences, Purdue Pharma (United States), Rutgers Cancer Institute, North Carolina State University
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: bronze
Awards: G1020433017, STUDIES TO EVALUATE THE TOXICITY OF SELECTED CHEMICALS, Profiles of Sucsceptibility to Toxicant Stress, G3112994418, Molecular Oncology and Toxicology Support, G3983138642, General Clinical Research Center, G4562040269, G664968150, G718490300, G9000247505, UNC Center for Environmental Health and Susceptibility, Mouse Phenome Project, Pre- and Postdoctoral Training in Toxicology, FURANOCOUMARINS AND DRUGS EFFECT ON CYP3A4
OpenAlex ID: W4299564802
